In recent years, advances in biomedical sciences are boosted by the introduction of new non-invasive imaging technologies. Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) or Computerized Tomography (CT), are now widely used to diagnose the development and progression of several pathologies, including cardiovascular diseases and cancer.
The integration of anatomic (CT) and functional (PET) imaging is emerging as a new diagnostic tool. PET, the most sensitive molecular imaging modality, combined with CT scans provides anatomical reference for lesion localization. However, PET/CT has drawbacks and limitations: requirement of radiation, and reduced soft tissue contrast when compared to MRI. In order to overcome these shortcomings, and thanks to the recent advances in the field, MRI has the potential to be considered as alternative of CT usage, and in combination with PET, excellent human anatomical information, superior soft tissue characterization, and temporal resolution would be reached.
The HYPERImage project drives the development of a brand new system for simultaneous whole-body PET-MR imaging for humans. The goal is not only to improve the existing diagnostic applications, but also to open up new fields in therapy guidance and therapy response monitoring. Sharing knowledge and resources of a leading medical company, three academic partners and three research institutes from five EU member states HYPERImage has a well positioned partner consortium. The project work packages are divided into three major research areas: hardware development, systems analysis development, and systems pre-clinical and clinical validation.
We combine leadership in technology with pioneer experience in the use of biomedical imaging. We strongly believe that PET-MR systems will dramatically improve the way to diagnose and to treat human disease.